#covaxine

[jloisse]

Mme Danielle Smith, première Ministre de l'Alberta présente ses excuses aux non-vaccinés er reconnait qu'ils ont été discriminés comme jamais aucun groupe auparavant.

[equiniveshlearn]

Try This U Will Get Good Results On Your Portfolio Return

#irfc #optiontrading #GIFTNIFTY #IRFC #NASDAQ #banknifty #hdfcbank #DowJones #RVNL #Maharashtra

#SEBI #Vedanta #zerodha $NOT #Baramulla #ManchalaManoj #Covaxin #VerifiedBySensibull #IPLPlayoffs

[memyself024]

AstraZeneca Admits its COVID Vaccine Can Cause Thrombosis

[newspatron]

The Vaccine War: Covaxin Chronicles - A Film Review

We hope you enjoyed reading our article about the film “The Vaccine War: Covaxin Chronicles”. We would love to hear your feedback, questions, or comments on the article. Please feel free to share your thoughts with us in the comment section below. Thank

The Vaccine War Covaxin Chronicles | Time to Read The Film Review The COVID-19 pandemic has been one of the most devastating and unprecedented events in human history. It has affected millions of lives, disrupted economies, and challenged the global order. However, it has also inspired remarkable feats of science, innovation, and cooperation. One of the most remarkable stories of the pandemic is…

[jornale]

#ricardobarros #stf #supremo #covaxin #vacina #vaccine #brasil #pandemia #saude #cpidacovid #news #noticias

[gofitnesspro]

How to keep yourself safer and protected from the new COVID-19 Variant XBB.1.5 of 2023?

New COVID-19 Variant XBB.1.5 What is XBB.1.5? The New COVID-19 variant XBB.1.5 was discovered for the first time in the US in New York in October 2022. It is a recombinant or hybrid virus subvariant, which means it consists of two strains, in this case, two descendants of the Omicron BA.2 sub lineage. The XBB.1.5 variation features a mutation that virologists think makes the virus more capable…

[jsbmarketresearch01]

Bharat Biotech Dispatches iNCOVACC to Hospitals, the Novel Intranasal Vaccine for COVID

Bharat Biotech had started dispatching iNCOVACC COVID vaccine, which is basically a nasal drop-based booster dose, the world’s first heterologous booster dose. Executive Chairman Dr. Krishna Ella said on 5 February that the distribution of the vaccine to hospitals began two days back and that India as evidenced by this vaccination can innovate for the nation and the rest of the world. He discussed vaccine delivery under the bilateral agreement. The agreement has taken place between UW-Madison Global Health Institute and Ella Foundation.

UW-Madison One Health Center is the sole establishment yet in India first of its kind for the improvement of global health education, medicines, and vaccines. The iNCOVACC COVID vaccination will help to reduce the cost of storage and disposal of biomedical waste. It will also cut the cost of production and distribution as there is no need for needles, syringes, bandages, and alcohol wipes.

The nasal vaccine is new to India, and Mansukh Mandaviya the Union Health Minister, had hinted in December about India’s technical expert committee on immunization was going to recommend the nasal vaccine against Corvid to the nation soon. Initially, the vaccine will follow a two-dose schedule along with a heterologous booster dose. It has been approved as an intranasal vaccine for COVID for the first time given as nasal drops.

It was initially on Republic Day 2023 that Mansukh Mandaviya and Union Minister of Science and Technology, Jitendra Singh launched iNCOVACC. Dr. Krishna Ella said on 26 January that the rollout of iNCOVACC has helped India in its goal of establishing a novel platform for vaccine delivery. The vaccine in question is the Adenovirus vaccine who’s Phase I, II, and III clinical trials have yielded positive results. It is a pre-fusion stabilized spike protein and a recombinant replication-deficient vaccine.

The vaccine cost is Rs. 325 per dose for large-scale purchases by the State and Central governments. The nasal drops are easy to administer and painless. It stays stable when stored at 2 to 8°C. Dr. Krishna Ella also expressed that India is well prepared for future infectious diseases and variants of the COVID-19 virus and we commit to developing novel vaccine technologies and innovating the same to combat infectious diseases for the good of public health globally.

Visit: - https://www.jsbmarketresearch.com/news/news-bharat-biotech-dispatched-incovacc-intranasal-vaccine

Follow us on social handles: -

YouTube: - https://youtube.com/shorts/yLVzPR9SgIs?feature=share

Facebook: - https://www.facebook.com/JSBMarketResearchGroup

Instagram: - https://www.instagram.com/p/CoUJj8RoLmO/?utm_source=ig_web_copy_link

Pinterest: - https://pin.it/3OkfEgt

LinkedIn: - https://www.linkedin.com/posts/jsbmarketresearch_incovacc-bharatbiotech-covidvaccine-activity-7028284693615624192-f9Rt?utm_source=share&utm_medium=member_desktop

Twitter: - https://twitter.com/JSBMarket/status/1622518806706020354?s=20&t=GMwuNSFbDCILyAhyFgG4Gw

[medhahospital]

One of the best Healtcare Facility in Ghaziabad....Medha Hospital and Trauma Centre 🏥🩺. Front view of Hospital 🏥. #healthcare #hospitalmanagement #ghaziabadhospital #ghaziabadhealth #pratapviharhospital #emergencyservices #emergencyservicesghaziabad #Vaccinationcentreghaziabad #covishield #covaxin (at Ghaziabad, India) https://www.instagram.com/p/CnizZ2OhFZt/?igshid=NGJjMDIxMWI=

[thesiliconreview1]

Novavax terminates COVID vaccine sale agreement with Gavi - The Silicon Review

Novavax Inc. confirmed that the termination has not resulted in any penalties.

The pharmaceutical company Novavax Inc. is considering terminating its association with Gavi, the Vaccine Alliance regarding the agreement for the sale of the company’s COVID-19 vaccine to low and middle-income countries. This decision is in line with Gavi’s failure to procure 350 million doses it had agreed to buy in May for the COVAX facility. COVAX facility is a joint program between the World Health Organization (WHO), Coalition for Epidemic Preparedness Innovations for the equitable distribution of COVID vaccines in the poorer countries. Novavax Inc. confirmed that the termination has not resulted in any penalties.

The company received a non-refundable advance payment of $350 million from Gavi and also an additional $350 million this year after the vaccine received WHO’s emergency use listing. The company also has a pact with Serum Institute of India for manufacturing a version of the vaccine under the brand Covovax, which is to be supplied to the COVAX facility. Serum Institute was expected to manufacture and sell around 750 million doses of Covovax to the facility. The decision is made as there was a poor demand for the company’s shot amid a global supply glut for Covid-19 vaccines and also the demand for the same was seeing a decrease.

[jloisse]

Les employeurs australiens ont reçu l'ordre de "détruire les données de vaccination Covid qui ont été collectées sur leurs employés" dans les 30 jours. On dirait bien que c'est la fin des haricots, maintenant ils essaient de cacher tous les crimes sous le tapis....

[equiniveshlearn]

Don't Waste Your Time

#GIFTNIFTY #IRFC #NASDAQ #banknifty #hdfcbank #DowJones #RVNL #equinivesh

#SEBI #Vedanta #zerodha $NOT #Baramulla #ManchalaManoj #Covaxin #VerifiedBySensibull #IPLPlayoffs

[thenewsfactsnow]

Bharat Biotech firmly condemns baseless reports on COVAXIN Development

Bharat Biotech Condemns Fallacious, misleading reports on COVAXIN , These efforts to discredit our work will not deter us , BB Stated Development #BharatBiotech #Covaxin #Covid19Vaccine

Bharat Biotech today strongly condemned fallacious and misleading information report recently by a foreign media. The company in a statement said -We condemn the targeted narrative against COVAXIN put forth by a select few individuals and groups who have no expertise in vaccines or vaccinology. It is well known that they helped perpetuate misinformation and fake news throughout the pandemic.…

[countryinsidenews]

दिल्ली / मोदी सरकार का फैसला- सरकार कोरोना का टीका नहीं खरीदेगी

दिल्ली / मोदी सरकार का फैसला- सरकार कोरोना का टीका नहीं खरीदेगी

सौरभ निगम की रिपोर्ट -दिल्ली / मोदी सरकार का फैसला- सरकार कोरोना का टीका नहीं खरीदेगी. मोदी सरकार ने फैसला किया कि कोरोनावायरस का खतरा अब कम होता दिखाई दे रहा है इसलिए आप कोई नया टीका नहीं खरीदा जाएगा. अगले 6 महीना के लिए टीकाकरण का पर्याप्त भंडार केंद्र सरकार के पास मौजूद है. टीकाकरण कार्यक्रम भी अब देश ने पूरा कर लिया है. कोरोना के केस अब देश में गिने-चुने मिल रहे हैं. केंद्रीय स्वास्थ्य…

[allthebrazilianpolitics]

Brazil Army colonel faces chop after speaking in putschist audios

Army Colonel Elcio Franco is set to be dismissed as advisor to the Brazilian Company of Blood Products and Biotechnology (Hemobras), linked to the Health Ministry, after it emerged he suggested moving Army troops to carry out a coup d’état in favor of former President Jair Bolsonaro last year. 

Mr. Franco served as the number two in the Health Ministry under Mr. Bolsonaro between 2020 and 2021, during the worst moments of the Covid pandemic in Brazil. He was appointed as the main negotiator in the allegedly fraudulent purchase of Covaxin vaccines. 

This week, CNN Brasil released audio recordings dating from December 2022, in which Mr. Franco tells Ailton Barros, a former army captain understood to be close with Mr. Bolsonaro, about the mobilization of 1,500 men for a putschist riot. The two men also complain about the Army command’s resistance to following this plan. 

Continue reading.

[puravibenamastes-blog]

CGU aplica multa de R$ 17,7 mi a laboratório indiano por fraude em venda de vacina contra Covid

A CGU (Controladoria-Geral da União) aplicou multa de R$ 17,7 milhões ao laboratório indiano Bharat Biotech por irregularidades na atuação da empresa no processo de aquisição da vacina Covaxin, destinada ao combate à Covid. A penalidade também inclui suspensão de participação em licitação e impedimento de contratação com a União por um ano. Leia mais (08/16/2024 – 17h55) Artigo Folha de S.Paulo –…